78 results match your criteria: "Kaiser Permanente Research Affiliates Evidence-based Practice Center[Affiliation]"
JAMA
July 2016
Group Health Research Institute, Kaiser Permanente Research Affiliates Evidence-based Practice Center, Seattle, Washington.
Importance: Skin cancer, primarily melanoma, is a leading cause of morbidity and mortality in the United States.
Objective: To provide an updated systematic review for the US Preventive Services Task Force regarding clinical skin cancer screening among adults.
Data Sources: MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials were searched for relevant studies published from January 1, 1995, through June 1, 2015, with surveillance through February 16, 2016.
JAMA
June 2016
Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon.
Importance: Colorectal cancer (CRC) remains a significant cause of morbidity and mortality in the United States.
Objective: To systematically review the effectiveness, diagnostic accuracy, and harms of screening for CRC.
Data Sources: Searches of MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant studies published from January 1, 2008, through December 31, 2014, with surveillance through February 23, 2016.
JAMA
April 2016
Kaiser Permanente Research Affiliates Evidence-based Practice Center, Portland, Oregon3Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
Importance: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States.
Objective: To systematically review literature on the accuracy of screening questionnaires and office-based screening pulmonary function testing and the efficacy and harms of treatment of screen-detected COPD.
Data Sources: MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant English-language studies published through January 2015.
JAMA
January 2016
Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Portland, Oregon.
Importance: Depression is a source of substantial burden for individuals and their families, including women during the pregnant and postpartum period.
Objective: To systematically review the benefits and harms of depression screening and treatment, and accuracy of selected screening instruments, for pregnant and postpartum women. Evidence for depression screening in adults in general is available in the full report.
JAMA Intern Med
October 2015
Pacific Northwest Evidence-Based Practice Center, Oregon Health & Science University, Portland.
Am J Prev Med
September 2015
Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Portland, Oregon.
Behavioral counseling interventions to promote healthy behaviors can significantly reduce leading causes of disease and death. Recommendations for delivery of these interventions in primary care have been and continue to be an important part of the U.S.
View Article and Find Full Text PDFThe importance of behavioral counseling as a clinical preventive service derives from the social and economic burden of preventable disease in the U.S., the central role behavioral risk factors play as leading causes of premature morbidity and mortality, and the promise of the healthcare visit as a teachable moment for behavioral counseling support.
View Article and Find Full Text PDFClin Cancer Res
March 2014
Authors' Affiliations: New Enterprise Associates, Inc., Menlo Park; CCS Associates, Mountain View; Myraqa, Redwood Shores, California; Johnson & Johnson/Veridex, LLC, Raritan, New Jersey; University of Texas, MD Anderson Cancer Center, Houston, Texas; Center for Diagnostics and Radiologic Health, Office of In Vitro Diagnostics, Personalized Medicine Program, Silver Spring; Center for Medical Technology Policy, Baltimore; Opus Three LLC; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Rockville, Maryland; and Kaiser Permanente Research Affiliates Evidence-Based Practice Center, Kaiser Permanente Center for Health Research, Portland, Oregon.
This article defines and describes best practices for the academic and business community to generate evidence of clinical utility for cancer molecular diagnostic assays. Beyond analytical and clinical validation, successful demonstration of clinical utility involves developing sufficient evidence to demonstrate that a diagnostic test results in an improvement in patient outcomes. This discussion is complementary to theoretical frameworks described in previously published guidance and literature reports by the U.
View Article and Find Full Text PDF